BRIEF-Basilea Pharmaceutica H1 net loss widens to CHF 30.1 mln

August 14, 2015 5:39 AM

31 0

* Announced today its financial results for first half of financial year 2015 with a solid half-year cash position of 218.4 million Swiss francs ($223.91 million)

* Revenues in H1 2015 amounted to 25.0 million Swiss francs (H1 2014: 20.3 million Swiss francs)

Also read: CDC: More Americans have epilepsy than in recent years

Read more

To category page